• Users Online: 66
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
   Table of Contents
Coverpage
September-December 2014
Volume 7 | Issue 3
Page Nos. 275-424

Online since Thursday, April 19, 2018

Accessed 969 times.

PDF access policy
Journal allows immediate open access to content in HTML + PDF
View as eBookView issue as eBook
Access StatisticsIssue statistics
RSS FeedRSS
Show all abstracts  Show selected abstracts  Export selected to  Add to my list
BOOK REVIEW  

With Head, Heart and Hands, Make a Medical Professional by Abdul Jabbar Mehdi Salih p. 275
Harald Rosen
DOI:10.7707/hmj.379  
HTML Full Text not available  [PDF]  [Sword Plugin for Repository]Beta
REVIEW FOR THE SHEIKH HAMDAN BIN RASHID AL MAKTOUM AWARD FOR MEDICAL SCIENCES Top

Imatinib (Glivec®) as a paradigm of targeted cancer therapies p. 277
Brian J Druker
DOI:10.7707/hmj.343  
[ABSTRACT]   HTML Full Text not available  [PDF]  [Sword Plugin for Repository]Beta

Drugging the cancer genome – discovery of small-molecule targeted therapeutics for personalized, precision medicine p. 289
Paul Workman
DOI:10.7707/hmj.344  
[ABSTRACT]   HTML Full Text not available  [PDF]  [Sword Plugin for Repository]Beta

Repurposing failed pharmaceuticals as the first targeted medicines for the treatment and prevention of breast cancer p. 305
V Craig Jordan
DOI:10.7707/hmj.345  
[ABSTRACT]   HTML Full Text not available  [PDF]  [Sword Plugin for Repository]Beta

Discovery of first-in-class therapeutics – venlafaxine (Effexor®), desvenlafaxine (Pristiq®), temsirolimus (Toresil®), ILS-920 and gemtuzumab ozogamicin (Mylotarg®) p. 317
Magid Abou-Gharbia
DOI:10.7707/hmj.346  
[ABSTRACT]   HTML Full Text not available  [PDF]  [Sword Plugin for Repository]Beta

Haematopoietic cell transplantation – from its birth to the twenty-first century p. 333
Rainer Storb
DOI:10.7707/hmj.347  
[ABSTRACT]   HTML Full Text not available  [PDF]  [Sword Plugin for Repository]Beta

Progress in vaccination p. 343
Stanley A Plotkin
DOI:10.7707/hmj.348  
[ABSTRACT]   HTML Full Text not available  [PDF]  [Sword Plugin for Repository]Beta

Cell therapy for cancer – our synthetic future p. 355
Carl H June
DOI:10.7707/hmj.349  
[ABSTRACT]   HTML Full Text not available  [PDF]  [Sword Plugin for Repository]Beta

The evolution of targeted therapy of the erbB2/neu oncoprotein for human cancer therapy p. 367
E Aaron Runkle, Mark I Greene
DOI:10.7707/hmj.351  
[ABSTRACT]   HTML Full Text not available  [PDF]  [Sword Plugin for Repository]Beta

Graft-versus-host disease, a major complication after stem cell transplantation – home care for prevention and stromal cells for therapy p. 375
Olle Ringden
DOI:10.7707/hmj.352  
[ABSTRACT]   HTML Full Text not available  [PDF]  [Sword Plugin for Repository]Beta

Inhibitors of the ‘point of no return’ in human immunodeficiency virus infectivity – discovery of novel antihuman immunodeficiency virus integrase compounds with dual mechanism of action p. 389
Vasu Nair, Maurice O Okello
DOI:10.7707/hmj.353  
[ABSTRACT]   HTML Full Text not available  [PDF]  [Sword Plugin for Repository]Beta

Antiproliferative and pro-apoptotic actions of oestrogen receptor β in prostate cancer p. 403
Jan-Ake Gustafsson, Anders Ström
DOI:10.7707/hmj.354  
[ABSTRACT]   HTML Full Text not available  [PDF]  [Sword Plugin for Repository]Beta

Rotarix™ from early discovery to widespread use p. 411
Richard L Ward, David I Bernstein
DOI:10.7707/hmj.356  
[ABSTRACT]   HTML Full Text not available  [PDF]  [Sword Plugin for Repository]Beta

The golden anniversary of the measles vaccine p. 421
Samuel L Katz
DOI:10.7707/hmj.357  
[ABSTRACT]   HTML Full Text not available  [PDF]  [Sword Plugin for Repository]Beta
  Next Issue
  Previous Issue